[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352624-105":59,"doc-detail-352624-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","targeting-cdk12-disrupts-estrogen-receptor-chromatin-recruitment-and-er-med1-transcription-in-advanced-er-breast-cancer","Targeting CDK12 disrupts estrogen-receptor chromatin recruitment and ER-MED1 transcription in advanced ERþ breast cancer","","Cyclin-dependent kinase 12 (CDK12) regulates gene transcription elongation and functions in RNA splicing, DNA damage response, cell cycle, and genomic stability, yet its CDK12-specific transcriptional partners remain unclear. Matched primary and brain metastatic tumors were profiled for CDK12 copy-number changes and gene expression, with immunohistochemistry in a large primary breast cohort. Results show CDK12 amplification and overexpression in brain metastases, linking high CDK12 protein to poor survival in ERþ disease.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/targeting-cdk12-disrupts-estrogen-receptor-chromatin-recruitment-and-er-med1-transcription-in-advanced-er-breast-cancer/352624/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/targeting-cdk12-disrupts-estrogen-receptor-chromatin-recruitment-and-er-med1-transcription-in-advanced-er-breast-cancer/352624.png","ImageObject",300,407,{"name":92,"@type":93},"Jacob","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does CDK12 play in gene regulation according to the document?","Question",{"text":112,"@type":113},"CDK12 regulates general gene transcription elongation and is implicated in RNA splicing, DNA damage response, cell cycle, and genomic stability.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What types of samples and experiments were used to study CDK12?",{"text":117,"@type":113},"CDK12 copy-number alterations and gene expression were analyzed in matched primary and brain metastatic patient tumors, followed by immunohistochemistry in a primary breast cancer cohort. Mechanistic studies included RNA sequencing and ChIP sequencing, with in vitro and in vivo pharmacological testing in advanced ERþ models.",{"name":119,"@type":110,"acceptedAnswer":120},"What key findings connect CDK12 to advanced ERþ breast cancer outcomes?",{"text":121,"@type":113},"CDK12 amplifications and gene overexpression were observed in brain metastatic tumors. In ERþ primary tumors, high CDK12 protein expression correlated with worse overall survival, especially in the ERþ/HER2-negative subgroup.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352624,1790179421,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},962084931830,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","JNCI: Journal of the National Cancer Institute, 2026, 118(3), 404–421  \n[https://doi.org/10.1093/jnci/djaf295](https://doi.org/10.1093/jnci/djaf295)  \nAdvance Access Publication Date: October 15, 2025  \nArticle  \nTargeting CDK12 disrupts estrogen-receptor chromatin recruitment and ER-MED1 transcription in advanced ERþ breast cancer  \nDaniela Ottaviani , PhD1, Mihaela Ola , PhD1, Alessandra Allotta , MSc1, Yasmine Maati Chaibi, MSc1, Sen Hickey , BSc1, PetraJagust , PhD1, Nicola Cosgrove , PhD1, Sinad Cocchiglia , MSc1, Fiona Bane , MSc1, Ramn Fallon , MSc1, Gordon Daly , MCh1, Aisling Hegarty , PhD1, 2, Lance Hudson , BSc1,2, Katherine Sheehan , MD1, 3, Shannon Kalsi , MSc1, Stephen Shovlin , PhD1, Aoibhn Powell , BSc1,4, Ash Bahl, PhD5, Ed Ainscow , PhD5, Steffi Oesterreich , PhD6, 7,  \nAdrian V. Lee , PhD6, 7, Fergus J. Couch , PhD8, Arnold D.K. Hill , MD9, DamirVarelija , PhD1,4, Leonie Young , PhD1, 2,9, 􀀃 1Endocrine Oncology Research Group, Department of Surgery, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin, Ireland 2Department of Surgery, Beaumont Hospital, Dublin, Ireland  \n3Department of Pathology, Beaumont Hospital, Dublin, Ireland  \n4The School of Pharmacy and Biomolecular Sciences, The Royal College of Surgeons University of Medicine and Health Sciences, Dublin, Ireland 5Carrick Therapeutics Ltd, Blanchardstown Corporate Park, Dublin, Ireland  \n6Women’s Cancer Research Center, Magee-Womens Research Institute, UPMC Hillman Cancer Center, Pittsburgh, PA 15213, United States 7Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA 15213, United States  \n8Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55901, United States 9Beaumont RCSI Cancer Centre, Beaumont Hospital, Dublin, Ireland  \n􀀃 Corresponding author: Leonie Young, PhD, Endocrine Oncology Research Group, Department of Surgery, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin D02 YN77, Ireland ([lyoung@rcsi.ie](lyoung@rcsi.ie)) .  \nAuthor Contributions: Daniela Ottaviani, Damir Varelija, and Leonie Young are joint senior authors.  \nAbstract  \nBackground: Cyclin-dependent kinase 12 (CDK12) regulates general gene transcription elongation and plays multiple roles in RNA splicing, DNA damage-response, cell cycle, and genomic stability. However, transcriptional partners that guide CDK12-specific gene programs have not been identified. Genomic alterations in CDK12 have been observed in multiple cancers, exhibiting both protumorigenic and tumor-suppressive functions, suggesting a context-dependent mechanism of action.  \nMethods: CDK12 copy number alterations and gene expression levels were analyzed in matched primary and brain metastatic patient tumors. Clinical significance was assessed by immunohistochemistry in a large cohort of primary breast cancer patient tumors. RNA sequencing, ChIP sequencing, and molecular studies were conducted to explore CDK12’s mechanism of action, and pharmacological studies were performed both in vitro and in vivo using models of advanced (endocrine-resistant and metastatic) estrogen receptor positive (ERþ) disease.  \nResults: CDK12 amplifications and gene overexpression were observed in brain metastatic tumors. In ERþ primary patient tumors, high CDK12 protein expression was significantly associated with poor overall survival, particularly within the ERþ/HER2-negative group. In ERþ endocrine resistant models, CDK12 regulated estrogen signaling pathways, with ER/MED1 identified as the master transcriptional complex directing CDK12-specific pro-tumorigenic gene programs. Pharmacological inhibition of CDK12 significantly reduced viability in endocrine resistant and metastatic cell and organoid models in vitro, and decreased metastatic spread in vivo. Conclusion: This work describes a novel mechanism for CDK12, suggesting a potential vulnerability in ERþ breast cancer. These findings provide a ba","cbCaiqM1FqEaNHJp","https://ap.wps.com/l/cbCaiqM1FqEaNHJp","pdf",4285478,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Author Contributions\n# Clinical and histopathological features","[{\"question\":\"What role does CDK12 play in gene regulation according to the document?\",\"answer\":\"CDK12 regulates general gene transcription elongation and is implicated in RNA splicing, DNA damage response, cell cycle, and genomic stability.\"},{\"question\":\"What types of samples and experiments were used to study CDK12?\",\"answer\":\"CDK12 copy-number alterations and gene expression were analyzed in matched primary and brain metastatic patient tumors, followed by immunohistochemistry in a primary breast cancer cohort. Mechanistic studies included RNA sequencing and ChIP sequencing, with in vitro and in vivo pharmacological testing in advanced ERþ models.\"},{\"question\":\"What key findings connect CDK12 to advanced ERþ breast cancer outcomes?\",\"answer\":\"CDK12 amplifications and gene overexpression were observed in brain metastatic tumors. In ERþ primary tumors, high CDK12 protein expression correlated with worse overall survival, especially in the ERþ/HER2-negative subgroup.\"}]","Targeting CDK12 disrupts estrogen-receptor chromatin recruitment and ER-MED1 transcription in advanced ERþ breast cancer | PDF",1790100525,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a3a4324a31283427f4875ac3e5044aad.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/55b5b66948fb8c3176b3a92a29fc9ee5.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/abb3ccb9a446de3bb306ebf44b7b08ea.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ed36837c5d42ccf635e2d31bef70c4fb.webp",980,1287]